Who owns ACTINIUM PHARMACEUTICALS INC?
- Ticker: ATNM
- CUSIP Number: 00507w206
Tip: Access positions for across all investors
Analyze quarterly positions in Actinium Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Actinium Pharmaceuticals stock
Who bought or sold ACTINIUM PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.4M | $1.9M | 3% | Dec 2025 |
|
| Vanguard Capital Management | 1.3M | $1.2M | 100% | Mar 2026 |
|
| Acadian Asset Management | 601k | $596k | -1% | Mar 2026 |
|
| Millennium Management | 565k | $562k | -6% | Mar 2026 |
|
| Renaissance Technologies | 391k | $532k | 35% | Dec 2025 |
|
| BlackRock | 371k | $370k | 1% | Mar 2026 |
|
| Two Sigma Investments | 337k | $336k | 61% | Mar 2026 |
|
| Geode Capital Management | 336k | $335k | 2% | Mar 2026 |
|
| Gagnon Securities | 201k | $200k | 0% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 160k | $160k | 100% | Mar 2026 |
|
| State Street Corporation | 126k | $172k | 0% | Dec 2025 |
|
| Gen-Wealth Partners | 107k | $107k | 0% | Mar 2026 |
|
| Citadel Advisors | 101k | $101k | -12% | Mar 2026 |
|
| Susquehanna International | 96k | $130k | -22% | Dec 2025 |
|
| Goldman Sachs Group | 70k | $70k | 0% | Mar 2026 |
|
| Jane Street | 61k | $60k | -51% | Mar 2026 |
|
| Northern Trust | 43k | $58k | 19% | Dec 2025 |
|
| Bridgeway Capital Management | 40k | $54k | 0% | Dec 2025 |
|
| Two Sigma Securities | 36k | $36k | 177% | Mar 2026 |
|
| Nine Masts Capital | 35k | $35k | 172% | Mar 2026 |
|
| Dimensional Fund Advisors | 35k | $35k | 0% | Mar 2026 |
|
| Vontobel Holding | 30k | $30k | 0% | Mar 2026 |
|
| Am Investment Strategies | 29k | $29k | 0% | Mar 2026 |
|
| XTX Topco | 26k | $35k | 30% | Dec 2025 |
|
| Gerald Baker Financial Group | 23k | $23k | 100% | Mar 2026 |
|
| Mayport | 22k | $22k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 20k | $28k | 183% | Dec 2025 |
|
| North Star Asset Management | 20k | $20k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 20k | $20k | 0% | Mar 2026 |
|
| Qube Research & Technologies | 19k | $26k | -27% | Dec 2025 |
|
| UBS Group | 15k | $15k | 15127% | Mar 2026 |
|
| FMR | 14k | $20k | -32% | Dec 2025 |
|
| Morgan Stanley | 14k | $14k | -29% | Mar 2026 |
|
| Callan Family Office | 12k | $12k | -49% | Mar 2026 |
|
| Intrepid Financial Planning Group | 11k | $11k | 0% | Mar 2026 |
|
| Savvy Advisors | 10k | $10k | 0% | Mar 2026 |
|
| Level Four Advisory Services | 10k | $14k | 0% | Dec 2025 |
|
| Vanguard Global Advisers | 8.9k | $8.8k | 100% | Mar 2026 |
|
| Rockefeller Capital Management | 4.0k | $4.0k | 0% | Mar 2026 |
|
| Steward Partners Investment Advisory | 2.2k | $2.2k | 0% | Mar 2026 |
|
| Federated Investors | 1.4k | $1.4k | 0% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 855.00 | $1.2k | 0% | Dec 2025 |
|
| Citigroup | 678.00 | $675.016800 | 100% | Mar 2026 |
|
| CWM | 620.00 | $999.998000 | -56% | Dec 2025 |
|
| SBI Securities | 542.00 | $539.019000 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 351.00 | $477.009000 | 0% | Dec 2025 |
|
| Pittenger & Anderson | 341.00 | $340.011100 | 0% | Mar 2026 |
|
| NISA Investment Advisors | 330.00 | $327.987000 | -66% | Mar 2026 |
|
| Investors Research Corp | 300.00 | $299.010000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 237.00 | $236.004600 | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 107.00 | $106.004900 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 45.00 | $0 | -99% | Mar 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 100% | Mar 2026 |
|
| Barclays | 1.00 | $1.000000 | -75% | Dec 2025 |
|
Who sold out of Actinium Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 196k | $267k |
| Squarepoint Ops | Dec 2025 | 66k | $89k |
| Bailard | Dec 2025 | 58k | $79k |
| Marshall Wace | Sep 2025 | 26k | $42k |
| Cetera Investment Advisers | Dec 2025 | 15k | $21k |
| Russell Investments | Dec 2025 | 13k | $18k |
| Hrt Financial | Dec 2025 | 13k | $17k |
| Point72 Asset Management | Dec 2025 | 10k | $14k |
| Advisory Services Network | Sep 2025 | 2.5k | $3.9k |
| Jpmorgan Chase & Co | Sep 2025 | 1.6k | $2.5k |
| SRS Capital Advisors | Dec 2025 | 707.00 | $962.014900 |
| Tower Research Capital | Sep 2025 | 555.00 | $888.000000 |
| EverSource Wealth Advisors | Dec 2025 | 16.00 | $22.000000 |
| Essential Partners | Dec 2025 | 4.00 | $5.000000 |